Efficient systemic treatment of dystrophic muscle pathologies
US10786546B2 · kind B2 · utility
2Cited by
0References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 9, 2018 |
| Grant date | Sep 29, 2020 |
| Priority date | — |
| Expiry date | Feb 2, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition comprising a gene therapy product for use in the treatment of a dystrophic disease in a subject, advantageously in humans, wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.